Source:http://linkedlifedata.com/resource/pubmed/id/15256735
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2004-7-16
|
pubmed:abstractText |
Silymarin, a plant flavonoid from milk thistle (Silybum marianum [L.] GAERTNER) was first evaluated for its protective effect against UV irradiation-induced apoptosis in human malignant melanoma cells (A375-S2 cells). Treatment with silymarin 500 microM for 12 h significantly inhibited UV irradiation (2.4 J/cm(2), 5 min)-induced apoptosis in A375-S2 cells. Activities of caspase-9 and caspase-3 in UV-irradiated A375-S2 cells were effectively reduced by silymarin in a dose-dependent manner, while the expression of the inhibitor of caspase-activated DNase (ICAD), protein expression of Bcl-x(L) (Bcl-2 family member), and the activity of extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) were increased simultaneously. It is suggested that the inhibitory effect of silymarin is exerted by blockage of the caspase/ICAD pathway after increased expression of Bcl-x(L) protein and activation of the ERK/MAPK pathway.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0918-6158
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1031-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15256735-Animals,
pubmed-meshheading:15256735-Apoptosis,
pubmed-meshheading:15256735-Cell Line, Tumor,
pubmed-meshheading:15256735-Cell Survival,
pubmed-meshheading:15256735-Dose-Response Relationship, Drug,
pubmed-meshheading:15256735-Dose-Response Relationship, Radiation,
pubmed-meshheading:15256735-Humans,
pubmed-meshheading:15256735-Silymarin,
pubmed-meshheading:15256735-Ultraviolet Rays
|
pubmed:year |
2004
|
pubmed:articleTitle |
Silymarin prevents UV irradiation-induced A375-S2 cell apoptosis.
|
pubmed:affiliation |
China-Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical University, China.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|